Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn's Disease and Complex Perianal Fistula

NCT04118088 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04118088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04118088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn's Disease and Complex Perianal Fistula
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Terminated
Start date
December 22, 2020
Completion date
February 14, 2025
Enrollment
53 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

complex perianal fistula, crohn's disease